Biomaterials Market Size, Share and Trends 2025 to 2035

Revenue, 2025

USD 192.43 Bn

Forecast Year, 2035

USD 569.49 Bn

CAGR, 2026 - 2035

11.46%

Report Coverage

Global

What is the Biomaterials Market Size?

The global biomaterials market size is valued at USD 192.43 billion in 2025 and is predicted to increase from USD 216.09 billion in 2026 to approximately USD 569.49 billion by 2035, growing at a CAGR of 11.46% from 2026 to 2035. The demand for biomaterials is initially driven by growing chronic diseases, an aging worldwide population, and developments in medical technology.

Key Takeaways

• North America has accounted revenue share of over 39% in 2025.
• Product, the polymer segment has accounted highest revenue share in 2025.
• Application, the orthopedic segment has held a revenue share of over 24% in 2025.

Market Overview

The biomaterials market is a wide-spread industry that revolves around the production and application of products or materials that interact with biological systems. These materials are used in multiple healthcare applications, such as implants, prosthetics and tissue engineering. The global market offers a wide range of materials like polymers, ceramics and composites, designed to be biocompatible and serve specific functions within the human body.

Biomaterials are widely used in dental applications, ophthalmology, cosmetic surgeries, drug delivery systems and wound healing. In addition, biomaterials are widely used to create various medical implants, such as artificial joints and cardiac stents.

The market's current position is observed to get accelerated as the industry is witnessing advancements in medical technology and improvements in the quality of healthcare services. Significant research and development activities are also observed to promote the market's expansion in the upcoming period.

AI in the Market

AI is playing a significant role in the transformation of the biomaterials market by fast-tracking the discovery, design, and optimization of new materials with the desired biological properties. Predictive modeling and generative algorithms allow the design of materials at the molecular level as per the clinical requirements. AI is a big help in the manufacturing process of 3D printing, electrospinning, and biofabrication, making sure that quality and consistency are maintained. In the biomedical field, AI is making it possible to have personalized biomaterials that are patient-specific, e.g., for drug delivery, implants, and tissue regeneration. Explainable AI (XAI) is the one giving confidence to researchers and doctors as it provides the transparency of the model predictions.

Biomaterials Market Growth Factors

Rising prevalence of chronic skeletal and musculoskeletal medical conditions are predicted to propel the demand for biomaterial-based implants, thereby fuelling the market growth. Further, technological advancements have made biomaterials more diverse and have increased their application in various fields such as tissue engineering and bioengineering. The advent of smart biomaterials drives the revenue generation in this market. Increasing demand for smart biomaterials that transfer and produce bioelectric signals similar to body tissues for accurate physiological functions predicted to surge the market growth. Piezoelectric scaffold is a smart material that plays a significant role in tissue engineering.

• Musculoskeletal disorders' increased prevalence is one of the reasons that biomaterial-based implants are rising.
• Better technologies are opening new avenues for the use of biomaterials in tissue engineering, bioengineering, and regenerative medicine.
• Smart biomaterials are coming up, which can imitate the natural tissue functions and, at the same time, give out bioelectric signals.
• More and more money is being invested in R&D for biomaterials, which will result in better biocompatibility, durability, and regenerative properties.
• The usage of biomaterials in healing wounds, repairing the heart, and in drug delivery systems is increasing.

Data and Statistics

• A global leader in biomaterial production and distribution, Evonik stated its expenditure for research and development activities to be €460 million in 2022. The company's sales reached €18.5 billion.
• Evonik's EBITDA reached €450 million in the second quarter (Q2) of 2023, which was €409 million in Q1 2023.
• MedTech by Johnson and Johnson, a prominent player for biomaterial production witnessed overall sales of $27.4 billion, this is an increase of 1.4% from 2021.
• The Canadian government in December 2022 invested $127 million in order to keep its bioscience facilities at cutting-edge. The investment has been made for research and development along with biomanufacturing purposes.
• According to American Joint Replacement Registry Annual Report for 2022, hip and knee procedures in America have registered a whopping growth of 14% as compared to the year 2021.

Market Outlook

• Industry growth overview: The industry development revolves around high-performance biomaterials, which are tailored materials crafted to communicate with biological machines for medical purposes, such as prosthetics, implants, and tissue engineering. Such materials are being classified by their ideal mechanical factors, such as bioactivity and biocompatibility, which make them necessary for different uses, including drug delivery systems, medical devices, and regenerative medicine.
• Global expansion: The complete demand for the biomaterials sector is witnessing a fast and upward demand, which is driven initially by a growing worldwide population, by the development of chronic diseases, and by a huge shift towards regenerative medicine.

Biomaterials Market Trends

• Nanotechnology -Driven Biomaterial Developments: Nanotechnology allows the influence of materials at the molecular and atomic range, which points to biomaterials with developed elements. For example, nanoparticles are used in polymers that have developed reactivity, surface area, strength, and biocompatibility.
• Application in Drug Delivery Systems: Biomaterial-dependent drug delivery systems have used nanotechnology and polymers to track the drug release of dosage and schedule. Such systems have developed treatment effectiveness while lowering the side effects by focusing on cells or tissues.
• Tailored and 3D Printing Implants: 3D printing has transformed biomaterial uses by generating patient-specific implants that have complicated geometries. By using composite and polymer materials, this method has tailored implants for dental applications, bone repair, and soft tissue systems.
• Tissue Engineering Methods: Tissue engineering depends heavily on biomaterials to make three-dimensional support structures. Such systems copy the extracellular material that assists in cell attachment, differentiation, and proliferation.
• Biomaterials for use in Wound Healing: Biomaterials aid wound healing by serving as secure barriers and assisting tissue repair. Foams, films, and hydrogels produced from factors like hyaluronic acid and alginate maintain a moist environment and protect against infections.

Market Scope

Market Dynamics

Driver

The rising rate of cosmetic surgeries

A report published by the International Society of Aesthetic Plastic Surgery stated that there was an overall 11.2% increase in procedures done by plastic surgeons in 2022. The report also stated that there were more than 14.9 million surgical procedures done in 2022 worldwide.

The demand for cosmetic surgeries and minimally invasive procedures has been on the rise in recent years. People are increasingly seeking enhancements to their physical appearance. This demand includes procedures such as facelifts and dermal fillers that require biomaterials. ongoing advancements in biomaterials have allowed safer and quicker cosmetic procedures. These biomaterials are designed to be biocompatible, reducing the risk of adverse reactions or complications. As the cosmetic industry expands, it is observed that the innovation of improved biomaterials will also increase. Thereby, the element is expected to sustain as a driver for the market.

Restraint

Regulatory hurdles

The market for biomaterials (production and distribution) is observed to be affected by regulatory hurdles or regulatory challenges. The market is subjected to strict regulatory oversight due to safety concerns. Meeting these requirements can be time-consuming and costly. Such regulatory hurdles can directly impact on the production or investment in biomaterials industry. Regulatory hurdles can even increase the timeline for production of biomaterials. Thereby, the element associated with regulatory hurdles acts as a major restraint for the market.

Opportunity

Innovation in techniques for biomaterial production

Technological advancements allow for the development of new biomaterials with enhanced properties. This also expands the range of materials available for various applications, catering to specific needs in the medical and healthcare sectors. Innovations in biomaterial production are observed to lead to materials that are more biocompatible for the human body. Innovations in the production of biomaterials also broaden the range of potential applications and increase patient safety. Thereby, the element is observed to offer several potential opportunities for the market to expand.

Segments Insights

Product Insights

By product, the polymer segment led the global biomaterials market with considerable revenue share in 2025 and projected to continue its dominance in the coming years. This is mainly attributed to the wide range of applications of polymer products. Wide availability of biopolymers along with need for advanced polymers for bio-resorbable tissue fixation application and other orthopedic applications expected to escalate the revenue growth of the segment.

Polymeric biomaterials are one of the keystones of tissue engineering. Continued progression in technologies, such as surface modification, micro manufacturing, nanotechnology, drug delivery, and high-throughput screening, play an important role in expanding the polymeric material usage in the tissue engineering field.

On the other hand, natural biomaterials anticipated to register the highest growth rate over the forecast period due to numerous benefits offered by the product over synthetic biomaterials related to biocompatibility, biodegradability, and remodeling. In the wake of these advantages, natural biomaterials are increasingly used for restoration and replacement of structure as well as function of the damaged tissues or organs.

Application Insights

The orthopedic application segment captured maximum revenue share in the global biomaterials market in 2025. Rising adoption of metallic biomaterials owing to their high load bearing capacity is one of the prime factors that drive the growth of the segment. Besides this, significant developments and on-going investments for the advancement in orthopedic implants by market participants are likely to propel the market growth in the next years to come. For instance, in November 2019, FDA approved Xiphos-ZF spinal interbody device introduced by DiFusion Inc. that is based on Zfuze, a different biomaterial that is made up of titanium and poly-ether-ether-ketone.

According to a study presented at the 2023 American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting. The study, “Epidemiology of Sports Injuries Among High School Athletes in the United States,” found that an estimated 5,228,791 sports injuries occurred nationally. The study notes that the epidemiologic data have been updated since 2006.

Moreover, plastic surgery analyzed to grow at a significant pace during the forecast period owing to increasing number of cosmetic procedures along with significant application of biomaterials in such surgeries. According to the International Society of Aesthetic Plastic Surgery report 2019, nearly 4.3 Million cosmetic procedures were performed in the U.S. during the year 2018 that positively influences the growth of the segment.

Regional Insights

Why Does North America Dominate the Global Biomaterials Market?

North America is the largest market for biomaterials, mainly thanks to its superior healthcare infrastructure, robust research ecosystem, and quick adoption of state-of-the-art medical technologies. The area's dedication to innovation and regulatory backing for medical device approvals allows for a quicker launch of new biomaterials in the market. The primary concentration on orthopedic, cardiovascular, and dental applications, together with massive funding for research institutions, is still reinforcing North America's dominance.

U.S. Biomaterials Market Size and Growth 2025 To 2035

The U.S. biomaterials market size was valued at USD 52.65 billion in 2025 and is expected to reach USD 156.87 billion by 2035, poised to grow at a CAGR of 11.54% from 2026 to 2035.

In terms of revenue, North America dominated the global biomaterials market due to initiatives taken by different private and public organizations. Some of the organizations include the National Institute of Standards and Technology and the National Science Foundation that provide assistance and knowledge pertaining to usage of biomaterials in various biomedical applications. This resulted in significant growth in the adoption of biomaterials in the region.

In May 2025, Nexture Bio unveiled a robust suite of custom research and development services. The services are designed to support customers in optimizing cell culture on ACF microcarriers and scaffolds, scaling adherent cell culture bioprocesses, formulating and building ACF microcarriers or scaffolds for their specific applications, and more. Services are delivered from two specialized facilities in Vacaville, California, and Xenia, Ohio, where each facility is purpose-built for biomaterials production and cell culture work.

The rising demand for cosmetic surgeries is anticipated to accelerate the market's revenue during the forecast period. For instance, according to the 2023 ASPS Procedural Statistics, cosmetic plastic surgery has steadily grown, as patients continue to place increased value on their physical and aesthetic health. In 2023, the number of Cosmetic Procedures reported by American Society of Plastic Surgery (ASPS) members rose by 5%. In 2022, 1,498,361 cosmetic plastic surgery procedures were performed, and in 2023, this number increased to 1,575,244. These procedures include breast, body, and facial plastic surgery procedures. Over 1.5 million cosmetic plastic surgeries were performed in the United States by American Society of Plastic Surgery (ASPS) members in 2023, an increase of 5% since 2022. Cosmetic Breast Procedures account for about one-third of all the cosmetic procedures performed by board-certified plastic surgeons. Breast Augmentation remains the most popular cosmetic breast procedure. In 2023, over 300,000 Breast Augmentations were performed.

Why Is Asia-Pacific the Fastest-Growing Biomaterials Market?

The Asia-Pacific region is the fastest-growing market, getting support from the improving healthcare facilities, a large elderly population, and the demand for both inexpensive and advanced medical solutions is rising. The local manufacturing capabilities development and the government's rising support for healthcare innovations are the other factors contributing to the market's growth. The fast adoption of regenerative medicine and bioprinting technologies is another thing that makes the region more competitive.

On the other hand, the Asia Pacific anticipated to witness the fastest growth during the analysis period. This is attributed to the major strategies adopted by the regional players to reinforce their presence in both global as well as regional market. For instance, in 2019, Mitsubishi Chemical, a Japan-based company, acquired thermoplastic polyurethane elastomer business from U.S.-based AdvanSource Biomaterials. The acquisition analyzed to help the company to expand its footprint in the global market along with capturing significant share in the international market.

India Market Analysis

In India, biomaterials deliver several strategic aims with the assistance of a single growth pathway. Primarily, they invest in eco-friendly sustainability by lowering the dependency on fossil fuels and lowering greenhouse gas emissions, which are linked with regular production. Secondarily, they deliver crucial economic and industrial possibilities that enable India to develop domestic potential in advanced materials and avoid reliance on imports.

Why Is the Europe Biomaterials Market Growing Steadily?

Europe is showing steady growth, which is the result of the continent's focus on quality healthcare, an aging population, and novelties in nanostructured and bio-inspired materials. Although the regulatory environment is stricter, the region still manages to make progress in orthopedic and cardiac biomaterials, thanks to strong links between industry and research, plus funding for R&D.

Germany Market Analysis

Germany's Biomaterials initiative has kept international students at the frontline of a medical discovery that integrates engineering accuracy with lifesaving uses in Europe's Euro 35 billion medical device market. It is being offered by top institutions like the University of Stuttgart, RWTH Aachen, and Charité Berlin; as such, English-taught college degrees have covered the complete biomaterials flow. This range of nanostructured scaffolds has directed biodegradable polymers and stem cells that serve as focused methods for intelligent materials that accept the bioinks and body for 3D-printed organs.

How is the Opportunistic Rise of the Middle East & Africa in the Market?

The Middle East & Africa (MEA) held nearly a 3% share of the liquid crystal polymer market in 2025 and is expected to grow in the coming years. The healthcare industry is being overshadowed by Iran, Saudi Arabia, Egypt, Israel, and the UAE, all of which together have covered more than most of the Middle East industry. Countries in this particular region have a big population that comes from all over the globe because of quickly developing economies, which have pointed towards tourism, oil, and the financial sector.

What Drives the Market Within Latin America?

Latin America held nearly a 5% share of the liquid crystal polymer market in 2025 and is projected to grow in the coming years, driven by BIOPOLIMERICA, which is a LABVA-started stage on biomaterials and biodesign that serves together for students, artists, and researchers with assistance of exhibitions, workshops, and public debates. This is initially summoned in Mexico, Medellín, and later in Valdivia, Chile, and Medellín, Colombia, to develop an environmental and cultural agency in official relation to materiality showcases, which behave as a main point for South American programs.

Key Companies & Market Share Insights

The global biomaterials market is highly competitive due to significant investments from market players to maintain a competitive edge and expand their presence. These vendors also adopt inorganic growth strategies such as partnerships, agreements, collaboration, and merger & acquisition to strengthen their product portfolio. They also invest in the development of biomaterials to expand their offerings.

Value Chain Analysis

• Feedstock Procurement: The process of obtaining biological raw materials such as plant-based compounds or agricultural residues for the production of biomaterials.
  Key Players: Stora Enso, Drax Group plc, Enviva Inc.
• Chemical Synthesis and Processing: The transformation of raw biological feedstocks into either functional chemical intermediates or the final forms of biomaterials.
  Key Players: SABIC, Corbion, and NatureWorks
• Compound Formulation and Blending: The mix of several materials to have the desired characteristics, like strength, elasticity, or biocompatibility.
  Key players: Evonik Industries, Corbion, Covestro AG, DuPont
• Quality Testing and Certification: The performance and regulatory compliance of the product are guaranteed through the stringent testing that is done.
  Key Players: TÜV Rheinland, Eurofins Scientific, Quality and Accreditation Institute (QAI)
• Regulatory Compliance and Safety Monitoring: The whole production chain is monitored for environmental, safety, and legal standards compliance.
  Key players: APCER Life Sciences, IQVIA

Competitive Landscape

The biomaterials market is consolidated, with worldwide manufacturers present. Academic research and development are developing valuable insights that can fill the further supplier items. Researchers globally are developing nanomaterials, hydrogel scaffolds, and bioinks for uses such as wound healing and cartilage repair. The sector's pipeline is high, with current ideas such as peptide-functionalized hydrogels for cartilage regeneration, as shown by Northwestern University in 2024. Additionally, single-use technologies (SUT) in general are under development across bioprocessing. As the industry feedback shows, 87% of biomanufacturers have grown their dependence on single-use disposable filtration systems.

Furthermore, regulatory compliance and sustainability have remained the main factors that have driven the design of bioprocess machines. Environmental selections are further driving the current designs, which are water-saving purification strategies, current facilities with lower energy usage, and brands that suggest their respective carbon footprint avoidance.

Biomaterials Market Companies

• Evonik Industries AG
• Medtronic plc
• Berkeley Advanced Biomaterials
• Corbion
• Carpenter Technology Corporation
• Zimmer Biomet Holdings, Inc.
• Invibio Ltd.
• Covalon Technologies Ltd.
• BASF SE
• Johnson & Johnson
• Stryker Corporation
• CoorsTek Inc.
• DentsplySirona
• Collagen Matrix, Inc.

Partnership in the Biomaterials Market

• CJ Biomaterials Inc, which is part of South Korea-dependent CJ CheilJedang, is a top leader in the manufacturing of polyhydroxyalkanoate (PHA) biopolymers, has revealed that it has signed an official partnership with a Swedish biomaterials compounding brand, BIQ Materials, and has extended the monetization of its patented artificial turf infill created by using PHACT PHA. (Source: https://cjbiomaterials.com)
• In September 2025, AMSilk and Evonik, which is a top leader in advanced biomaterials based on silk proteins, intensified their partnership with a long-term agreement to generate sustainable silk proteins on an industrial scale. (Source: https://www.evonik.com)
• Biomaterials company named Erthos has merged with Colgate-Palmolive to partner on Erthos” AI-linked stage named Zya, whose goal is sustainable materials growth. Zya will assist the user, a packaged goods company, that has an online design in terms of biopolymer packaging materials, which aligns with their sustainability and specifications encouragement. (Source: https://www.packagingdive.com)
• In December 2025, Tetratheriz disclosed a crucial step towards its US-based joint company, BioOptix, which is an ophthalmic biomaterials company that has entered into a growth agreement with the worldwide eye-care leader, Alcon Research. (Source: https://biotechdispatch.com)

Segments Covered in the Report

By Product

• Metallic
• Ceramics
• Natural
• Polymers

By Application

• Ophthalmology
  • Intraocular Lens
  • Synthetic Corneas
  • Ocular Tissue Replacement
  • Others
• Cardiovascular
  • Stents
  • Sensors
  • Implantable Cardiac Defibrillators
  • Guidewires
  • Vascular Grafts
  • Pacemakers
  • Others
• Dental
  • Dental Implants
  • Tissue Regeneration Materials
  • Bone Grafts & Substitutes
  • Others
• Wound Healing
  • Adhesion Barrier
  • Surgical Hemostats
  • Fracture Healing Device
  • Internal Tissue Sealant
  • Skin Substitutes
  • Others
• Orthopedic
  • Orthobiologics
  • Joint Replacement Biomaterials
  • Viscosupplementation
  • Spine Biomaterials
  • Bioresorbable Tissue Fixation Products
  • Others
• Plastic Surgery
  • Soft Tissue Fillers
  • Facial Wrinkle Treatment
  • Bioengineered Skins
  • Craniofacial Surgery
  • Acellular Dermal Matrices
  • Peripheral Nerve Repair
  • Others
• Tissue Engineering
• Neurology
  • Shunting Systems
  • Neural Stem Cell Encapsulation
  • Cortical Neural Prosthetics
  • Hydrogel Scaffold For CNS Repair
  • Others
• Others

By Region

• North America
• Latin America
• Europe
• Asia-pacific
• Middle and East Africa